In collaboration with Canadian pet nutraceutical company Adored Beast Apothecary in Moncton, NB, Dr. Vasantha Rupasinghe in the Faculty of Agriculture is developing a manufacturing process for pet nutraceutical products to help manage cancers of dogs.
In this current pre-clinical investigation, Dr. Rupasinghe’s lab is funded by Adored Beast Apothecary and Mitacs for the assessment of four natural health product preparations for their ability to reduce the cancer-development process through their anti-oxidant, anti-inflammatory and cytotoxic effects on tumours.
Postdoctoral Fellow and CRTP Alum Dr. Madu Amararathna is examining both cancer preventative and treatment properties of the new natural health products using an established experimental animal model of chemical carcinogen-induced cancer. The expected result will become useful for the Adored Beast Apothecary to proceed with the clinical dog study and progress with the business development plan and commercialization. This industry collaboration has already led to the filing of a patent on a new manufacturing process and formulation and the publication of two peer-reviewed original research articles.
Left to right: Dr. Vasantha Rupasinghe, Julie Anne Lee DCH, the founder, head of R&D and formulator of Adored Beast Apothecary, Dr. Madu Amararathna, a postdoctoral fellow, and co-owner Dione Albert.
Please view the full article